Loading…

A PHASE 1/2 STUDY OF MT‐3724 TO EVALUATE SAFETY, PHARMACODYNAMICS AND EFFICACY OF MT‐3724 FOR THE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA

Saved in:
Bibliographic Details
Published in:Hematological oncology 2019-06, Vol.37 (S2), p.566-566
Main Authors: Burnett, C.A., Hamlin, P., Dabovic, K., Higgins, J., Persky, D.O.
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0278-0232
1099-1069
DOI:10.1002/hon.13_2632